A 2018 review of sixteen experiments of cannabis-primarily based medicines for neuropathic pain, the majority of which tested a cannabinoid planning referred to as nabiximols (brand name title Sativex; a mouth spray made up of both of those THC and CBD that is certainly accepted in a few interna